Physician profile
Jason Mackay
NPI 1821525965
$10,341.05
in general payments reported to CMS, 2019-2025
16 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,182 · 2020: $585 · 2021: $1,014 · 2022: $1,194 · 2023: $5,122 · 2024: $1,127 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,364.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $6,200.00 | 2022-2024 | M22 |
| Alcon Vision LLC | $1,799.35 | 2019-2025 | Precision 1, Dailies Total1, Total30 |
| Coopervision INC. | $538.96 | 2019-2024 | Paragon Crt, Ortho-K Contact Lens, Myday Contact Lens |
| Maculogix, INC. | $383.96 | 2019-2020 | |
| Shire North American Group INC | $320.00 | 2019 | |
| Abb Con-Cise Optical Group LLC | $261.47 | 2019-2020 | |
| Johnson & Johnson Surgical Vision, INC. | $216.40 | 2022-2025 | Lipiflow System Activator (Disposable) |
| Carl Zeiss Meditec USA, INC. | $205.84 | 2021-2023 | Forum |
| Johnson & Johnson Vision Care, INC. | $135.19 | 2019-2022 | |
| Sight Sciences, INC. | $72.89 | 2023 | Tearcare System |
| Kala Pharmaceuticals, INC. | $58.16 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $55.79 | 2019-2020 | |
| Optos, INC. | $35.18 | 2022 | |
| Dompe US, INC. | $23.98 | 2025 | Oxervate |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $14.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Mackay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.